Squarepoint Ops LLC Aytu Biopharma, Inc Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.08 - $1.55 $10,893 - $15,634	-10,087 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.35 - $2.95 $13,617 - $29,756	10,087 New	10,087 $14,000
Q3 2021 Nov 15, 2021	SELL	$2.78 - $5.12 $95,873 - $176,573	-34,487 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.73 - $7.56 $163,123 - $260,721	34,487 New	34,487 $173,000
Q1 2021 May 17, 2021	SELL	$6.23 - $9.88 $217,190 - $344,436	-34,862 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.98 - $13.5 $208,474 - $470,637	34,862 New	34,862 $208,000

Ticker AYTU
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 62,432,700
Market Cap $97.4M
Description
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.